Gentronix Limited’s Post

View organization page for Gentronix Limited, graphic

2,530 followers

We understand how including genetic #toxicology in the early drug discovery phase is a key step in improving the safety profile of the chemical series under development. It also increases the chance of project success by avoiding late-stage toxicology failures. At Gentronix, our combination of the 24-well Ames and 96-well in vitro micronucleus tests enables all mechanisms of genotoxicity to be assessed in methods consistent with the regulatory battery across responsive timelines and using minimal test item amounts. Read more about the benefits here👉https://lnkd.in/evJtmge6

To view or add a comment, sign in

Explore topics